Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Wolfsburg – page 2

34 clinical trials in Wolfsburg, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wolfsburg at a glance
34
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

34 trials in Wolfsburg

Open in trial search
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Hot flush

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.

Adenocarcinoma gastric+3

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astellas Pharma Global Development Inc.
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:RNMB1
  • Sponsor:Sanofi Pasteur Inc.
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1
  • Sponsor:Sanofi Pasteur Inc.
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Paraffin White Soft
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Methylprednisolone Aceponate
  • Sponsor:Dermapharm AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wolfsburg

What the registry says about research in the country

01 Oncology Research

Comprehensive studies focusing on gastrointestinal cancers, including innovative treatments for esophageal and gastric adenocarcinomas. Multiple trials evaluating combination therapies with immunotherapy agents.

  • Advanced Gastric Cancer
  • Ovarian Cancer
  • Rectal Cancer

Investigating novel treatment approaches including targeted therapies and immunotherapy combinations.

02 Hematologic Malignancies

Groundbreaking research in acute lymphoblastic leukemia treatments, particularly focusing on pediatric and adolescent patients. Studies include novel therapeutic combinations and targeted approaches.

  • Lymphoma Treatment
  • Philadelphia Chromosome-positive ALL
  • Diffuse Large B-Cell Lymphoma

Emphasis on personalized treatment strategies and improved outcomes for blood cancers.

03 Preventive Medicine

Studies examining preventive approaches for various conditions, including meningococcal infection prevention through vaccination and dermatological interventions.

  • Vaccine Development
  • Atopic Dermatitis Prevention
  • Post-Surgical Care

Focus on early intervention and disease prevention strategies in diverse patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.